Navigation Links
InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
Date:8/20/2007

ome the support and collaboration of a leader in the UK blood pressure monitoring market as RESPeRATE expands its reach through broader channels," said Jon Collings, UK Country Manager of InterCure. "Omron's strength in the diagnostic market will help expand the presence of InterCure's revolutionary RESPeRATE technology within the UK, furthering our current efforts to provide a safe, alternative treatment option to hypertension patients worldwide."

"A marketing collaboration with InterCure complements our existing product offering in the hypertension marketplace within the United Kingdom," said Steve MacAleese, General Manager, Omron Healthcare (UK). "We understand the value of not only offering a modality to diagnose the issue but to also provide an innovative treatment option for hypertension patients."

About RESPeRATE

RESPeRATE(R) is FDA-cleared for over-the-counter sale and is the only medical device on the market clinically proven to lower blood pressure through paced breathing therapy. The device uses the body's natural tendency to follow external rhythms, interactively guiding the user to effortlessly reduce their breathing rate to a "therapeutic zone" of less than 10 breaths per minute. The breathing exercises with RESPeRATE relax the constricted muscles surrounding the small blood vessels, allowing the blood to flow more freely and yielding a significant and lasting reduction of blood pressure within weeks.

About InterCure, Ltd.

InterCure, a medical device company, publicly traded on the Tel Aviv Stock Exchange (TASE: INCR) has become a leader in the growing Personal Therapeutic Device category. Its broadly patented "device-guided breathing" technology platform enables a systematic reduction in sympathetic outflow of the autonomic nervous system. InterCure is successfully selling the world's first hypertension treatment device, RESPeRATE(R), with more than 75,000 units sold. With multiple published clinical studies, regulatory
'/>"/>

SOURCE InterCure, Ltd.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Web-based reporting credited with states top healthcare ranking
2. Visions: Preizler offers insurers perspective on healthcare IT
3. Federal bill would set healthcare IT standards
4. IRS ruling could speed healthcare technology adoption
5. Bill would provide federal aid for healthcare IT
6. DHC 2007: Hayden says technology creates magic moment for healthcare delivery
7. Digital Healthcare Conference 2007: Mounting obstacles for health IT
8. Georgia healthcare system to install GEs radio frequency ID
9. GE Healthcare leads compact ultrasound market
10. CIO Leadership Series: Greg Smith, Wheaton Franciscan Healthcare
11. Merge Healthcare suffers $258M loss in `06
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Calif. , May 17, 2013  Cellular ... has achieved 50% enrollment of the total projected ... evaluate the safety and preliminary efficacy of the ... therapy for Knee Osteoarthritis (KOA). To date the ... reported. The Phase I open label ...
(Date:5/17/2013)... May 17, 2013  Insero Health, Inc., a company ... epilepsy and related neurological disorders, is today reporting top-line ... compound INS001 in patients with drug-resistant epilepsy.  The data ... Trials (AED) Xll meeting by Dr. Steven ... of Insero,s Scientific Advisory Board.  In this study, INS001 ...
(Date:5/17/2013)... Frederick, MD (PRWEB) May 17, 2013 ... release of ezColony version 4.1, a versatile refinement ... world-class premier software solution, improves its advanced methodical ... animal facilities with ezColony 4.1. The network-based platform ... to conduct effective research. While continuing to emphasize ...
(Date:5/17/2013)... May 17, 2013 Tooth decay is an ... active signs of the disease. The World Health Organization says ... 100% of adults have cavities. What are the long-term effects ... showing a strong connection between the oral bacterial imbalance and ... disease so rampant, yet it is also 100% preventable? Answer: ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... 2008 RiverVest Venture Partners,announced today that it ... Fund II, L.P., with total committed capital of ... was licensed,as a Small Business Investment Company, had ... of leverage from the Small Business Administration., ...
... and JERSEY CITY, New Jersey, April 11, Rosetta ... development of microRNA-based diagnostics and therapeutics, announced,today it ... AACR,conference in San Diego. The posters will include ... they may be applied to develop,objective and standardized ...
... 2008 In the event of an outbreak or ... responsible for virulence or drug resistance is essential to ... analysis of a pathogen genome is time-intensive and likely ... developed a comparative genomics strategy to drastically reduce the ...
Cached Biology Technology:RiverVest Venture Partners(R), a St. Louis-Based Venture Capital Firm Focusing on Life Sciences, Closes on Fund II, Names John P. McKearn, Ph.D., Venture Partner 2RiverVest Venture Partners(R), a St. Louis-Based Venture Capital Firm Focusing on Life Sciences, Closes on Fund II, Names John P. McKearn, Ph.D., Venture Partner 3Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference 2Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference 3Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference 4Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference 5Scientists develop strategy to rapidly describe outbreak strains with next-generation DNA sequencing 2
(Date:5/16/2013)... Abwe, a conservationist working in Cameroon and the manager ... just been awarded the prestigious Whitley award. The ... called "The Green Oscars" because it celebrates the extraordinary ... in developing countries. Abwe was selected for the ... preserve Cameroon,s Ebo Forest and its wildlife inhabitants., HRH ...
(Date:5/16/2013)... The consultancy Frost & Sullivan ... Germany,s largest biometrics manufacturer, DERMALOG ... DERMALOG has been honored yesterday night by ... the category Global Biometrics and Border Control  Customer Value ... Border Control System . One of the decisive factors ...
(Date:5/15/2013)... PHILADELPHIA In the largest clinical trial to date ... BRCA 1/2 carriers with diseases other than breast and ... be effective against advanced pancreatic and prostate cancers. Results ... School of Medicine at the University of Pennsylvania and ... presented during the American Society of Clinical Oncology,s annual ...
Breaking Biology News(10 mins):Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4PARP inhibitor shows activity in pancreatic, prostate cancers among patients carrying BRCA mutations 2
... cetaceanswhales, dolphins and porpoisesfirst dipped their toes into water, a ... swimming mammals into the larger hoofed animal group. But what ... carnivorous diet, or the loss of their ability to walk? ... resolves this debate using a massive data set of ...
... electron microscopy techniques, a team led by researchers from ... the precise arrangement of chemoreceptorsthe receptors that sense and ... found that this specific architecture is the same throughout ... this is a stable, universal structure that has been ...
... at Cold Spring Harbor Laboratory (CSHL) are among an ... the director of the National Institutes of Health (NIH) ... Professor Partha Mitra, Ph.D., and Assistant Professor Josh ... by the NIH today -- in letters addressed to ...
Cached Biology News:Getting a leg up on whale and dolphin evolution 2Getting a leg up on whale and dolphin evolution 3Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells 2Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells 3Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells 42 neuroscientists from Cold Spring Harbor Laboratory awarded 'transformative' NIH grants 22 neuroscientists from Cold Spring Harbor Laboratory awarded 'transformative' NIH grants 32 neuroscientists from Cold Spring Harbor Laboratory awarded 'transformative' NIH grants 4